PT1156830E - Utilizacao de uma emulsao oleo em agua para a preparacao de um medicamento - Google Patents

Utilizacao de uma emulsao oleo em agua para a preparacao de um medicamento

Info

Publication number
PT1156830E
PT1156830E PT00914043T PT00914043T PT1156830E PT 1156830 E PT1156830 E PT 1156830E PT 00914043 T PT00914043 T PT 00914043T PT 00914043 T PT00914043 T PT 00914043T PT 1156830 E PT1156830 E PT 1156830E
Authority
PT
Portugal
Prior art keywords
disease
chronic
acute
infections
water emulsion
Prior art date
Application number
PT00914043T
Other languages
English (en)
Inventor
Heinrich Exner
Peter Klose
Original Assignee
Heinrich Exner
Peter Klose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Exner, Peter Klose filed Critical Heinrich Exner
Publication of PT1156830E publication Critical patent/PT1156830E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00914043T 1999-02-24 2000-02-23 Utilizacao de uma emulsao oleo em agua para a preparacao de um medicamento PT1156830E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19910161 1999-02-24

Publications (1)

Publication Number Publication Date
PT1156830E true PT1156830E (pt) 2006-05-31

Family

ID=7900130

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00914043T PT1156830E (pt) 1999-02-24 2000-02-23 Utilizacao de uma emulsao oleo em agua para a preparacao de um medicamento

Country Status (10)

Country Link
EP (1) EP1156830B1 (pt)
JP (1) JP4383678B2 (pt)
AT (1) ATE315408T1 (pt)
AU (1) AU3550400A (pt)
CA (1) CA2364606C (pt)
DE (2) DE50012052D1 (pt)
DK (1) DK1156830T3 (pt)
ES (1) ES2255988T3 (pt)
PT (1) PT1156830E (pt)
WO (1) WO2000050085A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10113284A1 (de) 2001-03-16 2002-10-02 Heinrich Exner Adjuvans-Emulsion und Verfahren zu deren Verwendung
DE10313196A1 (de) * 2003-03-19 2004-10-07 Exner, Heinrich, Dr.med.vet. Verwendung einer Emulsion zur Prophylaxe und Therapie von Erkrankungen bei Tieren und Menschen
JP2005075752A (ja) * 2003-08-29 2005-03-24 Nippon Inst For Biological Science 豚繁殖・呼吸障害症候群用ワクチン製剤
DE10353792A1 (de) * 2003-11-13 2005-06-23 Exner, Heinrich, Dr.med.vet. Heil- und Wundsalbe auf der Basis einer wässrigen Emulsion
DE102005009515A1 (de) 2005-02-25 2006-09-07 Exner, Heinrich, Dr. Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren
DE102007007698A1 (de) * 2007-02-09 2008-08-21 Exner, Heinrich, Dr. Verwendung einer hochemulgierten Silikonöl-Emulsion (HSE)zur Herstellung eines Medikamentes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4445074A1 (de) * 1993-12-09 1995-06-29 Exner Heinrich Dr Med Vet Adjuvans für Antigene, Verfahren zur Herstellung und Verwendung
WO1995015768A1 (de) * 1993-12-09 1995-06-15 Heinrich Exner Adjuvans für antigene, verfahren zur herstellung und verwendung

Also Published As

Publication number Publication date
JP4383678B2 (ja) 2009-12-16
DK1156830T3 (da) 2006-05-29
WO2000050085A3 (de) 2000-12-28
EP1156830B1 (de) 2006-01-11
EP1156830A2 (de) 2001-11-28
AU3550400A (en) 2000-09-14
DE50012052D1 (de) 2006-04-06
JP2002537359A (ja) 2002-11-05
ATE315408T1 (de) 2006-02-15
CA2364606C (en) 2012-02-14
ES2255988T3 (es) 2006-07-16
WO2000050085A2 (de) 2000-08-31
DE10080402D2 (de) 2002-05-08
CA2364606A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
US20230128449A1 (en) Silicate containing compositions and methods of treatment
JP2009280627A5 (pt)
NZ239558A (en) Pharmaceutical compositions containing perfluorinated hydrocarbons and silicones as liquid carriers
BR9702362A (pt) Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação.
MXPA01006474A (es) Derivados colquinol como agentes perjudiciales vasculares.
JP2002363097A5 (pt)
GB0814302D0 (en) Compounds and methods
YU54499A (sh) Farmaceutski preparat za primenu na mukozu
PT1156830E (pt) Utilizacao de uma emulsao oleo em agua para a preparacao de um medicamento
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
PL1684719T3 (pl) Kompozycje alfa 1-antytrypsyny i sposoby leczenia z zastosowaniem takich kompozycji
AU2007209850B2 (en) Composition based on salts of hyaluronic acid for treating epithelial lesions
KR970705563A (ko) 항바이러스제로서의 4-(2-아미노-6-(시클로프로필아미노)-9H-푸린-9-일)-2-시클로펜텐-1-메탄올 숙시네이트(4-(2-Amino-6-(Cyclopropylamino)-9H-Purin-9-yl)-2-Cyclopentene-1-Methanol Succinate as Antiviral Agent)
JP2001322936A (ja) 眼科用組成物
RU2008126108A (ru) Фармацевтическая композиция для лечения остеоартрита, содержащая клодроновую кислоту и гиалуроновую кислоту
US20150174245A1 (en) Transparent gel
CO5170447A1 (es) Derivado de benzamida y medicamento que lo contiene
WO2005016246A3 (en) Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
WO2022041634A1 (zh) 一种预防病毒传染的复方制剂及其配制/使用方法与应用
BRPI0411572A (pt) microemulsões transnasais contendo diazepam
JP2021506905A (ja) 血液中のＣａｎｄｉｄａ ａｕｒｉｓを処置するための方法および医薬組成物
WO1997024374A1 (fr) Solution stable contenant du hyaluronate de sodium
JPH09110702A (ja) 海洋深層水含有ゲル製剤
WO2006118488A2 (en) Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions
HUP0302371A2 (hu) Béta-blokkolót és adott esetben koleszterinszint-csökkentőt tartalmazó új gyógyszerkészítmény